Novel Drug Granted FDA FAST TRACK DESIGNATION.

Subjects

Subjects :

NEUROENDOCRINE tumors
PEMBROLIZUMAB
OVERALL survival
ANTINEOPLASTIC agents

Details

Language :

English

ISSN :

15347664

Volume :

23

Issue :

1

Database :

Complementary Index

Journal :

CURE: Cancer Updates, Research & Education

Publication Type :

Periodical

Accession number :

177371659